SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GME is trending as the community discusses potential connections to the recent surge in meme stocks, particularly $BYND. Some traders are drawing parallels to the 2021 meme stock craze, while others remain skeptical about GME's ability to replicate similar gains, especially with discussion around Roaring Kitty and warrant issues.

$WAGMI is a community-driven meme token built on the Solana blockchain, designed to bring positivity, unity, and humor into the crypto space. The project encourages community engagement through memes, social interaction, and token-based activities. It leverages Solana’s fast and low-cost infrastructure to allow for smooth on-chain interactions, such as token transfers, community games, and NFT integration. The goal is to foster a fun, inclusive ecosystem where holders feel they are part of a larger movement – "We Are Gonna Make It."

WAGMI

WAGMI is trending as community members express strong bullish sentiment and highlight its consistent growth within the Solana ecosystem. Talk centers around the potential for a significant run, emphasizing community strength and long-term vision. The community is focused on the "We're all gonna make it" narrative.

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflix is trending due to a post-earnings dip, driven by a reported miss in EPS attributed to a one-time Brazilian tax issue, sparking debates about its valuation. The community is discussing potential downgrades and the impact on the broader market, while some view the dip as a buying opportunity, anticipating a rebound. Concerns about subscriber growth, content quality and production costs are also circulating.

Solana is a highly functional open source project that banks on blockchain technology’s permissionless nature to provide decentralized finance (DeFi) solutions. It is a layer 1 network that offers fast speeds and affordable costs. While the idea and initial work on the project began in 2017, Solana was officially launched in March 2020 by the Solana Foundation with headquarters in Geneva, Switzerland.

Solana

Solana is trending, with community members frequently mentioning "WAGMI" and "Pump". Hong Kong's approval of a Solana spot ETF by ChinaAMC appears to be a key catalyst, sparking discussions about potential price movements and broader crypto market trends. Some traders are also watching for breakouts above key resistance levels.

IREN Ltd. is a vertically integrated data center business powering the future of Bitcoin, AI and beyond with renewable energy. It is strategically located in renewable-rich, fiber-connected regions across the US and Canada. IREN’s large-scale, grid-connected facilities are purpose-built for the next generation of power-dense computing applications. The company was founded by Daniel Roberts and William Roberts on November 6, 2018, and is headquartered in Sydney, Australia.

IREN Ltd.

IREN Limited

IREN is trending amidst a sector-wide pullback, leading to community debate about the stock's near-term direction and potential support levels. Discussions include concerns about market manipulation, comparisons to other high-growth stocks, and confidence in the company's long-term potential within the AI data center space. Despite recent price drops, some investors remain optimistic, citing strong fundamentals and potential catalysts.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

DJT is trending amidst discussions around Trump's potential influence and actions, including a recent request for funds from the DOJ. Community talking points revolve around the political implications and the stock's future performance. The conversations also touch on the broader economic landscape under different administrations.

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

NBIS is trending as investors debate whether the recent dip presents a buying opportunity or signals further decline, with some pointing to a potential AI sector rotation. Community members are closely watching support levels and anticipating upcoming earnings for a catalyst. The stock's volatility and recent red days have fueled discussions about its valuation and future growth potential amid broader market conditions.

SPDR Gold Trust - SPDR Gold Shares ETF

SPDR Gold Shares ETF

GLD is experiencing significant volatility, with community members discussing potential flash crashes and heavy institutional selling. Some traders believe gold has hit its peak for 2025, while others see this as a buying opportunity amidst global economic uncertainty and geopolitical tensions. Discussions also include gold's relationship to the dollar, potential rate cuts, and shifts in market sentiment.

Minerva Neurosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of a portfolio of product candidates to treat central nervous system diseases. It develops Roluperidone for the treatment of negative symptoms in patients with schizophrenia and MIN-301 for the treatment of Parkinson’s disease. The company was founded by Rogerio Vivaldi Coelho and Goeffrey Robin Race on April 23, 2007 and is headquartered in Burlington, MA.

Minerva Neurosciences Inc

NERV is trending due to a recently announced financing deal of up to $200 million to advance its schizophrenia treatment, roluperidone, through Phase 3 trials, leading to significant price movement. The community is actively discussing key price levels and potential for continued upside, while some traders express caution regarding possible dilution or short selling. Overall sentiment suggests excitement around the funding milestone and potential FDA catalyst, balanced with awareness of potential risks.

Omeros Corp. operates as a biopharmaceutical company. The firm engages in the discovery, development, and commercializing of both small-molecule and protein therapeutics for large market. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

Omeros Corporation

Omeros ($OMER) is trending due to a recent licensing deal with Novo Nordisk potentially worth $2.1 billion, sending the stock soaring. While some community members express concern about potential retracement and short selling, others see long-term value, especially with upcoming FDA decisions. Discussions include potential buyout scenarios, approval timelines, and the impact of the deal on the company's financials.

statis crypto Watchlist

Bitcoin

Ethereum

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Johnson & Johnson Targets Accelerated Growth Across Segments in 2026

J&J projects faster 2026 growth in Innovative Medicine and MedTech, topping consensus estimates on both revenues and EPS.

Here is What to Know Beyond Why Amgen Inc. (AMGN) is a Trending Stock

Amgen (AMGN) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

FDA APPROVES TEZSPIRE FOR CHRONIC RHINOSINUSITIS WITH NASAL POLYPS

FDA APPROVES TEZSPIRE FOR CHRONIC RHINOSINUSITIS WITH NASAL POLYPS FDA APPROVES TEZSPIRE FOR CHRONIC RHINOSINUSITIS WITH NASAL POLYPS PR Newswire THOUSAND OAKS, Calif., Oct. 17, 2025 Approval...

The Zacks Analyst Blog Highlights Eli Lilly, Novo Nordisk, Amgen and Viking Therapeutics

Eli Lilly's blockbuster GLP-1 drugs, Mounjaro and Zepbound, are driving explosive growth as the company prepares to report Q3 results.

How Will Mounjaro and Zepbound Sales Aid Lilly's Upcoming Q3 Results?

Strong demand for Mounjaro and Zepbound is expected to power LLY's Q3 growth, as both drugs deepen U.S. and global market reach.

Amgen (AMGN) Laps the Stock Market: Here's Why

In the closing of the recent trading day, Amgen (AMGN) stood at $297.32, denoting a +1.18% move from the preceding trading day.

JNJ Beats on Q3 Earnings, Ups Sales View, to Spin-off Orthopaedics Unit

J&J tops Q3 forecasts, lifts 2025 sales outlook and plans to spin off its struggling Orthopaedics business.

Why Amgen (AMGN) Could Beat Earnings Estimates Again

Amgen (AMGN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Buying J&J Stock Ahead of Q3 Earnings? Here's What You Should Know

J&J gears up for Q3 results with solid gains from Darzalex, Tremfya and MedTech, even as Stelara faces fierce biosimilar pressure.

Is Novo Nordisk Stock a Sell Despite its 10% Price Rally in a Month?

NVO's 10% stock price rally masks deeper challenges as competition, restructuring and slower growth weigh on its outlook.

Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.

AMGEN Inc.

Will Netflix ($NFLX) beat quarterly earnings? 
 
*Powered by Polymarket

Stocktwits

) beat quarterly earnings? 
 
*Powered by Polymarket

Fiscal Period	Estimated	Reported	Surprise	Result
Q3 '25	$5.04	--	--	N/A
Q2 '25	$5.28	$6.02	13.98%	BEAT
Q1 '25	$4.27	$4.90	14.76%	BEAT
Q4 '24	$5.08	$5.31	4.47%	BEAT
Q3 '24	$5.11	$5.58	9.27%	BEAT

AMGN
AMGEN Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q3 '25

Historical Earnings

Latest AMGN News

AMGNAMGEN Inc.